Browse life science companies throughout Northern Ireland, including biotechnology firms, research organisations and innovation centres.
AI-designed antibody biologics adapting human therapeutics for companion animals
Antigenesis Biologics is a biotechnology company developing targeted biological treatments for companion animals, applying expertise in human antibody therapeutics to address a gap between human and veterinary healthcare innovation. The company uses AI and computational design approaches to develop antibody-based…
Life sciences and health innovation network for Northern Ireland
The Health Innovation Research Alliance Northern Ireland is a not-for-profit organisation acting as the single representative voice for Northern Ireland's life and health sciences sector. HIRANI connects industry, academia, health organisations, and government to drive collaboration, promote the region's capabilities…
Rapid diagnostic tests for Leptospirosis in animals and humans
Linnodee is a Northern Ireland-based manufacturer of in vitro diagnostic tests for the detection of Leptospirosis across animal and human health applications. Operating from ISO 9001 and ISO 13485-accredited facilities in Ballyclare, the company develops and manufactures ELISA, agglutination, and lateral flow-based…
Reprogrammed stem cell therapies for vascular disease and chronic wounds
ReproGo is a Belfast-based regenerative medicine company developing Advanced Therapy Medicinal Products through direct cell reprogramming of adult cells into vascular lineages. The company's manufacturing approach produces stem cell-derived vascular cells and organoids through a xeno-free, low-dose process designed…
AI drug discovery platform developing novel biologics for cancer and AMR
AMPLY Discovery is a biotechnology company developing an AI-driven drug discovery platform that combines machine learning, next-generation sequencing, and synthetic biology to identify novel biologic drug candidates from natural biological diversity. The platform digitises biological molecules, identifies treatment…
Contract pharmaceutical development, manufacturing and diagnostic services
Almac Group is a privately owned contract development and manufacturing organisation providing integrated services across the drug development lifecycle to pharmaceutical and biotechnology clients. Capabilities span API and peptide synthesis, formulation development, GMP clinical and commercial manufacturing, clinical…
Spectroscopy-based food authentication and adulteration detection testing
Bia Analytical is a food authentication testing laboratory providing spectroscopy and data science-based methods to detect adulteration in food ingredients. The company uses FTIR and NIR spectroscopy combined with chemometrics to authenticate herbs, spices, and other high-value ingredients, supporting food producers,…
Oxygen-generating nanoparticles to overcome hypoxia in solid tumours
StimOxyGen is a preclinical-stage biotechnology company developing pH-responsive nanoparticle formulations to address tumour hypoxia, a major barrier to effective cancer treatment. The technology uses a biodegradable polymer coating that dissolves in the acidic tumour microenvironment, transiently generating localised…
Contract antibody discovery, engineering and supply services
Fusion Antibodies is a contract research organisation specialising in preclinical antibody discovery, engineering and supply for pharmaceutical and diagnostic clients. Services span antigen expression, antibody generation, humanisation, affinity maturation, developability optimisation, and stable cell line…
Phase 1 clinical research and bioanalytical services for drug development
Celerion is a contract research organisation specialising in early-stage clinical research for pharmaceutical and biotechnology clients. Operating from a dedicated Phase 1 clinic in Belfast, the company conducts first-in-human studies, bioequivalence and bioavailability trials, cardiac safety studies, and ADME…
IVD and companion diagnostics regulatory consultancy and CRO
ARC Regulatory is a contract research organisation and regulatory consultancy specialising in in vitro diagnostics and companion diagnostics for precision medicine clinical trials. The company provides regulatory strategy, clinical trial management, quality management, and assay validation services to pharmaceutical…
Active protease biomarker assays for respiratory disease diagnostics
ProAxsis is a diagnostics company developing and supplying laboratory immunoassays and point-of-care tests for the measurement of active protease biomarkers in respiratory disease. Using patented activity-based capture technology, the company's assays quantify neutrophil elastase and proteinase 3 as indicators of…
Targeted nanoparticle formulations for nucleic acid delivery
XapHe is a biotechnology company developing peptide-based nanoparticles for therapeutic nucleic acid delivery. Its HAWC platform packages RNA and DNA payloads into formulations designed for cell entry and tissue targeting. The company supplies transfection kits and offers custom nanoparticle formulation services for…
Experimental diabetes research into insulin and metabolic therapies
Centre for Diabetes is an Ulster University research centre in Coleraine investigating the molecular mechanisms of diabetes and emerging treatment approaches. Its research includes pancreatic beta-cell dysfunction, insulin secretion, glycation, glucose-regulating peptides and experimental antidiabetic compounds. The…
Non-surgical drug therapy for spinal cord injury recovery
NeuroSolv Therapeutics is a preclinical-stage biotechnology company developing a non-surgical two-part therapy for spinal cord injury. The proposed mechanism combines enzymatic removal of perineuronal nets on spinal cord neurons with treatment of signal-blocking glial scar tissue, enabling new synaptic connections to…
Cell therapy for vascular regeneration in ischaemic and wound healing conditions
VascVersa is a Belfast-based regenerative medicine company developing cell therapies for vascular regeneration and repair. The company's technology uses vasoreparative cells to stimulate new blood vessel formation and restore blood supply in conditions characterised by impaired circulation. The lead programme targets…
AI-powered multi-omic data analytics for precision medicine
Sonraí Analytics is a software company providing cloud-based AI and bioinformatics analytics for pharmaceutical, biotechnology and clinical research organisations. The platform integrates multi-omic, imaging, and clinical data within a secure research environment to support drug target identification, biomarker…
Clinical chemistry reagents and diagnostic products for human and veterinary use
Glenbio is a Northern Ireland-based manufacturer of in vitro diagnostic reagents, specialising in clinical chemistry reagents and liquid stable protein formulations for use across multiple analyser platforms. Operating from ISO 13485-accredited manufacturing and testing facilities in Antrim, the company supplies…
Precision medicine diagnostic commercialisation platform and data analytics
Diaceutics is a data analytics and services company providing pharmaceutical and biotechnology clients with an end-to-end solution for the commercialisation of precision medicine diagnostics. The company integrates real-world diagnostic testing data from a global network of over 52,000 laboratories, applying machine…
Preclinical vaccines targeting antimicrobial-resistant bacterial infections
VacTimmune is a biotechnology company developing preventative vaccines against bacterial pathogens associated with antimicrobial resistance. Its preclinical pipeline includes candidates targeting Pseudomonas aeruginosa, Klebsiella pneumoniae and other clinically important bacteria, with an emphasis on infections…